IBDEI11H ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16891,1,3,0)
 ;;=3^Peritonitis Female Pelvic,Unspec
 ;;^UTILITY(U,$J,358.3,16891,1,4,0)
 ;;=4^N73.5
 ;;^UTILITY(U,$J,358.3,16891,2)
 ;;=^5015817
 ;;^UTILITY(U,$J,358.3,16892,0)
 ;;=N72.^^61^777^38
 ;;^UTILITY(U,$J,358.3,16892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16892,1,3,0)
 ;;=3^Inflammatory Disease Cervix Uteri
 ;;^UTILITY(U,$J,358.3,16892,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,16892,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,16893,0)
 ;;=N76.3^^61^777^99
 ;;^UTILITY(U,$J,358.3,16893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16893,1,3,0)
 ;;=3^Vulvitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,16893,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,16893,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,16894,0)
 ;;=N76.1^^61^777^95
 ;;^UTILITY(U,$J,358.3,16894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16894,1,3,0)
 ;;=3^Vaginitis,Subacute & Chronic
 ;;^UTILITY(U,$J,358.3,16894,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,16894,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,16895,0)
 ;;=N76.2^^61^777^98
 ;;^UTILITY(U,$J,358.3,16895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16895,1,3,0)
 ;;=3^Vulvitis,Acute
 ;;^UTILITY(U,$J,358.3,16895,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,16895,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,16896,0)
 ;;=N76.0^^61^777^94
 ;;^UTILITY(U,$J,358.3,16896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16896,1,3,0)
 ;;=3^Vaginitis,Acute
 ;;^UTILITY(U,$J,358.3,16896,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,16896,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,16897,0)
 ;;=M00.20^^61^777^3
 ;;^UTILITY(U,$J,358.3,16897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16897,1,3,0)
 ;;=3^Arthritis Streptococcal,Unspec Joint
 ;;^UTILITY(U,$J,358.3,16897,1,4,0)
 ;;=4^M00.20
 ;;^UTILITY(U,$J,358.3,16897,2)
 ;;=^5009645
 ;;^UTILITY(U,$J,358.3,16898,0)
 ;;=M00.80^^61^777^4
 ;;^UTILITY(U,$J,358.3,16898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16898,1,3,0)
 ;;=3^Arthritis d/t Bacteria,Unspec Joint
 ;;^UTILITY(U,$J,358.3,16898,1,4,0)
 ;;=4^M00.80
 ;;^UTILITY(U,$J,358.3,16898,2)
 ;;=^5009669
 ;;^UTILITY(U,$J,358.3,16899,0)
 ;;=M00.9^^61^777^77
 ;;^UTILITY(U,$J,358.3,16899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16899,1,3,0)
 ;;=3^Pyogenic Arthritis,Unspec
 ;;^UTILITY(U,$J,358.3,16899,1,4,0)
 ;;=4^M00.9
 ;;^UTILITY(U,$J,358.3,16899,2)
 ;;=^5009693
 ;;^UTILITY(U,$J,358.3,16900,0)
 ;;=M00.00^^61^777^83
 ;;^UTILITY(U,$J,358.3,16900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16900,1,3,0)
 ;;=3^Staphylococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,16900,1,4,0)
 ;;=4^M00.00
 ;;^UTILITY(U,$J,358.3,16900,2)
 ;;=^5009597
 ;;^UTILITY(U,$J,358.3,16901,0)
 ;;=M00.10^^61^777^69
 ;;^UTILITY(U,$J,358.3,16901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16901,1,3,0)
 ;;=3^Pneumococcal Arthritis,Unspec Joint
 ;;^UTILITY(U,$J,358.3,16901,1,4,0)
 ;;=4^M00.10
 ;;^UTILITY(U,$J,358.3,16901,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,16902,0)
 ;;=M86.20^^61^777^65
 ;;^UTILITY(U,$J,358.3,16902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16902,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,16902,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,16902,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,16903,0)
 ;;=M86.10^^61^777^61
 ;;^UTILITY(U,$J,358.3,16903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16903,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,16903,1,4,0)
 ;;=4^M86.10
